Prognostic Impact of Tumor Growth Velocity in Head and Neck Squamous Cell Carcinoma Treated by Radio(Chemo)Therapy
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Clinical Trials Related to Head and Neck Squamous Cell Carcinoma
Related studies linked through entity extraction aliases.
Phase I/II Study OF Metformin in Combination With Cisplatin and Radiation in Head and Neck Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
The Study to Evaluate Toripalimab (JS001) in Patients With Advanced GC, ESCC, NPC, HNSCC
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Study of PEP503 With Radiotherapy in Combination With Concurrent Chemotherapy for Patients With Head and Neck Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Pembrolizumab in HNSCC With Residual Disease After Radiation
- Status
- TERMINATED
- Phase
- PHASE2
Anti-tumor Specific Immune Response in Head and Neck Cancers
- Status
- UNKNOWN
- Phase
- N/A
Predictive Value of Diffusion-weighted MRI Performed in Early Post-treatment in the Occurrence of Tumor Recurrence or Progression in Head and Neck Squamous Cell Carcinoma Treated With Chemoradiotherapy: a Pilot Study
- Status
- COMPLETED
- Phase
- NA
Intraoperative Placement of Cesium-131 Permanent Interstitial Brachytherapy in Head and Neck Cancer
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Comparison of Concomitant Cisplatin Versus Carboplatin and 5-fluorouracil With Radiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- N/A
Pembrolizumab in Combination With Cisplatin and Intensity Modulated Radiotherapy (IMRT) in Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
TumorGraft- Guided Therapy for Improved Outcomes in Head and Neck Squamous Cell Cancer- A Feasibility Study
- Status
- COMPLETED
- Phase
- NA
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
- Status
- RECRUITING
- Phase
- PHASE2
BGJ398 in Treating Patients With FGFR Positive Recurrent Head and Neck Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Head and Neck Squamous Cell Carcinoma (HNSCC)PET-CT Pilot Study
- Status
- RECRUITING
- Phase
- NA
DAHANCA 30: A Randomized Non-inferiority Trial of Hypoxia-profile Guided Hypoxic Modification of Radiotherapy of HNSCC.
- Status
- UNKNOWN
- Phase
- PHASE3
A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study to Evaluate the Efficacy and Safety of Docetaxel Polymeric Micelle (PM) in Recurrent or Metastatic HNSCC
- Status
- UNKNOWN
- Phase
- PHASE2
Chemoprevention of Head and Neck Squamous Cell Carcinoma (HNSCC) With Valproic Acid
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Pharmacodynamic Effects and Predictive Biomarkers With Ruxolitinib in Operable Head and Neck Cancer
- Status
- WITHDRAWN
- Phase
- EARLY_PHASE1
Bupropion Hydrochloride or Patient's Choice for Smoking Cessation in Patients With Squamous Cell Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy
- Status
- TERMINATED
- Phase
- EARLY_PHASE1